Radiology · 2003 · 167 citations · 47 references
MedicineOncologyUrologyDiagnostic ImagingDiagnostic RadiologyProstate DiseaseMagnetic Resonance ImagingMagnetic Resonance SpectroscopyMetabolic EvaluationProstate CancerProstate Cancer ImagingTumor Imaging1D Proton Nuclear Magnetic Resonance SpectroscopyCholine ImagingMagnetic ResonanceMagnetic Resonance Spectroscopic ImagingMetabolic Tumor ImagingMetabolite ImagingProstate Cancer DiagnosisProstate Metabolism
PURPOSE: To determine whether cancers of the prostate transition zone (TZ) possess a unique metabolic pattern by which they may be identified at proton magnetic resonance (MR) spectroscopic imaging. MATERIALS AND METHODS: Findings in 40 patients who underwent combined endorectal MR imaging and hydrogen 1 MR spectroscopic imaging before radical prostatectomy and who had TZ tumor identified subsequently at step-section pathologic analysis were retrospectively reviewed. Within this population, a subset of 16 patients whose TZ tumor had a largest diameter of 1 cm or greater and was included in the MR spectroscopic imaging excitation volume was identified. In these 16 patients, the ratios of choline-containing compounds (Cho) and creatine/phosphocreatine (Cr) to citrate (Cit) (ie, [Cho + Cr]/Cit), Cho/Cr, and Cho/Cit were compared in tumor and control tissues. The presence of only Cho and the absence of all metabolites were also assessed. RESULTS: The mean values of (Cho + Cr)/Cit, Cho/Cr, and Cho/Cit were different between TZ cancer and control tissues (P =.001, P =.003, and P =.001, respectively; Wilcoxon signed rank test). Nine (56%) of 16 patients had at least one tumor voxel in which Cho comprised the only detectable peak, while no control voxels showed only Cho (P =.008, McNemar test). The percentage of voxels in which no metabolites were detected did not differ between tumor and control tissues (P =.134, McNemar test). CONCLUSION: TZ cancer has a metabolic profile that is different from that of benign TZ tissue; however, the broad range of metabolite ratios observed in TZ cancer precludes the use of a single ratio to differentiate TZ cancer from benign TZ tissue.
47
Practical Nonparametric Statistics
David J. Groggel, W. J. Conover · Technometrics · 2000 · 11.1K citations
Zonal Distribution of Prostatic Adenocarcinoma
John E. McNeal, Elise A. Redwine, Fuad S. Freiha et al. · The American Journal of Surgical Pathology · 1988 · 1.2K citations